ภาษาไทย
English
PR Newswire - Speakly AI Shines at VivaTech 2024 with Its LLM-ba...
MOUNTAIN VIEW, Calif. , May 30, 2024 /PRNewswire/ -- Speakly AI, a pioneer in conversation intellige...
Read more
PR Newswire - XCMG Excavator Unveils New G-Series Line up for Gl...
XUZHOU, China, May 30, 2024 /PRNewswire/ -- XCMG Excavator , a specialized excavator business unit ...
Read more
PR Newswire - Royal Caribbean Group Introduces Industry-First Lo...
On its pursuit to transform a vacation of a lifetime into a lifetime of vacations, Royal Caribbean G...
Read more
PR Newswire - International Airport to Integrate 3CLogic with De...
Global provider of AI and contact center solutions to streamline customer interactions, reduce manua...
Read more
PR Newswire - CIMC Vehicles's H Share Buy-back Offer Closed...
H Shares to Delist at 4 pm on 3 June HONG KONG, May 30, 2024 /PRNewswire/ -- CIMC Vehicles (Group) C...
Read morePR Newswire - "Disrupt" introduces Disrupt Health Impact Fund wi...
BANGKOK, May 30, 2024 /PRNewswire/ -- Disrupt Technology Venture ("Disrupt") announced the introduct...
Read more
PR Newswire - ActiveOps becomes Official Analytics Partner to Gr...
Highlighting the necessity of data-driven decision-making as a central tenet to both athletes on ...
Read morePR Newswire - Global Times: A glimpse into China's groundbreakin...
BEIJING, May 30, 2024 /PRNewswire/ -- A 20-foot container-shaped storage tank is placed at a dock on...
Read morePR Newswire - ActiveOps becomes Official Analytics Partner to Gr...
Highlighting the necessity of data-driven decision-making as a central tenet to both athletes on ...
Read more
PR Newswire - TOOsonix receives MDR CE Mark for its new oncology...
The EU Medical Device Regulation CE certification approves that the most common types of skin cancer...
Read more
PR Newswire - Teikoku Pharma USA, Inc. Announces NMPA Approved L...
SAN JOSE, Calif., May 30, 2024 /PRNewswire/ -- Teikoku Pharma USA (TPU) announced today that the NMP...
Read morePR Newswire - Ivonescimab Monotherapy Decisively Beats Pembroliz...
Monotherapy Ivonescimab Achieved Clinically Meaningful PFS Benefit in HARMONi-2 Trial Conducted b...
Read more